Status:
UNKNOWN
CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
Lead Sponsor:
Fudan University
Conditions:
Colorectal Cancer
Circulating Tumor Cell
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
This study enrolled patients who underwent R0 resection of tumor and had elevated tumor biomarkers (CEA, CA19-9). After enroll the study, a CTC test will performed and patients who had positive CTC wi...
Eligibility Criteria
Inclusion
- Age 18-80 years;
- Histologically proven colorectal cancer
- All the lesion (s) has been R0 resected
- Have elevated tumor biomarker (CEA or CA19-9) in three consecutive tests
- More than 1 CTC has been detected (including 1)
- ECOG 0-1
- Hematology tests suggest that they can tolerate chemotherapy
- Written informed consent for participation in the trial
Exclusion
- Have any radiological evidence of recurrence
- Other previous malignancy within 5 years
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04917289
Start Date
June 1 2021
End Date
December 1 2025
Last Update
June 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.